SE:ISOFOL Stock Latest News
Company AnnouncementsIsofol to Present at Four Investor Meetings in December9h ago
Company AnnouncementsIsofol Sets SEK 0.95 Exercise Price for TO2 Warrants6d ago
Company AnnouncementsIsofol Reports Interim Results and Arfolitixorin Study Update1w ago
Company AnnouncementsIsofol Reports Preliminary Disease Control in Arfolitixorin Trial1w ago
Company AnnouncementsIsofol Sets AGM 2027 Nomination Committee as Cancer Drug Development Advances3w ago
Company AnnouncementsIsofol schedules investor updates to showcase new data on cancer drug arfolitixorin1M agoCompany AnnouncementsIsofol Deepens Arfolitixorin Push as Cash Reserves Bolster Pre-Revenue Pipeline2M ago
Company AnnouncementsIsofol expands arfolitixorin cancer trial to accelerate patient recruitment2M ago
Company AnnouncementsIsofol advances arfolitixorin trial with final dose cohort in colorectal cancer study4M ago
Company AnnouncementsIsofol Medical AGM Backs New Incentive Schemes and Withholds 2025 Dividend6M ago
Company AnnouncementsIsofol strengthens finances and advances arfolitixorin trial in first quarter6M ago
Company AnnouncementsIsofol Expands Share Capital After Warrant Exercise6M agoCompany AnnouncementsIsofol Wins Regulatory Nod to Broaden and Speed Up Key Arfolitixorin Trial7M ago
Company AnnouncementsIsofol publishes 2025 reports as arfolitixorin program shows progress7M ago
Company AnnouncementsIsofol Raises 18.9 MSEK via TO1 Warrant Exercise and Directed Share Issue7M ago
Company AnnouncementsIsofol Extends Arfolitixorin Rights Into Autism While Keeping Cancer Focus8M ago
Company AnnouncementsIsofol Sets TO1 Warrant Price and Exercise Window, Targets SEK 19 Million Raise8M ago
Company AnnouncementsIsofol Secures Stakeholder Support Covering 42% of Upcoming TO1 Warrant Exercise8M ago

